GVS advice concerning siponimod (Mayzent®) for the treatment of secondary progressive multiple sclerosis
van der Waal JM, Wijma S
Record ID 32018001612
Dutch
Original Title:
GVS advice Mayzent® (siponimod)
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2020/11/16/gvs-advice-concerning-siponimod-mayzent
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Multiple Sclerosis, Chronic Progressive
- Drug Therapy
- Azetidines
- Sphingosine 1 Phosphate Receptor Modulators
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.